| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/03/2023 | Oyster Point Pharma, Inc. | OYST | Other | Common Stock | 5.9M | $0.00 | $0 | | 01/03/2023 |
| 04/06/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 255.5k | $1.10 | $281.8k | | 04/05/2022 |
| 04/05/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 439.1k | $1.07 | $469.4k | | 04/05/2022 |
| 01/25/2022 | Casper Sleep Inc. | CSPR | Other | Common Stock | 6.2M | $6.90 | $42.9M | | 01/25/2022 |
| 01/25/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 103k | $1.47 | $151.8k | | 01/21/2022 |
| 01/24/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 20k | $1.55 | $31k | | 01/21/2022 |
| 01/21/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 11.6k | $1.67 | $19.4k | | 01/21/2022 |
| 01/20/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 6.3k | $1.81 | $11.4k | | 01/18/2022 |
| 01/19/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 13.4k | $1.82 | $24.4k | | 01/18/2022 |
| 01/18/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 6.8k | $1.89 | $12.9k | | 01/18/2022 |
| 01/14/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 9.7k | $1.91 | $18.6k | | 01/12/2022 |
| 01/13/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 7.2k | $1.93 | $13.9k | | 01/12/2022 |
| 01/12/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 4.6k | $2.02 | $9.4k | | 01/12/2022 |
| 01/11/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 2.4k | $2.04 | $4.9k | | 01/07/2022 |
| 01/10/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 1.8k | $2.00 | $3.5k | | 01/07/2022 |
| 01/07/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 14.6k | $2.08 | $30.3k | | 01/07/2022 |
| 01/06/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 10.3k | $2.16 | $22.2k | | 01/04/2022 |
| 01/05/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 8.2k | $2.25 | $18.4k | | 01/04/2022 |
| 01/04/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 13.5k | $2.34 | $31.5k | | 01/04/2022 |
| 01/03/2022 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 44.7k | $2.34 | $104.4k | | 12/30/2021 |
| 12/31/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 50k | $2.25 | $112.4k | | 12/30/2021 |
| 12/30/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 21.9k | $2.29 | $50.1k | | 12/30/2021 |
| 12/29/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 15.2k | $2.30 | $35k | | 12/27/2021 |
| 12/28/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 24.6k | $2.34 | $57.5k | | 12/27/2021 |
| 12/27/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 27.7k | $2.42 | $67k | | 12/27/2021 |
| 12/23/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 24k | $2.41 | $57.7k | | 12/09/2021 |
| 12/22/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 20.1k | $2.32 | $46.7k | | 12/09/2021 |
| 12/21/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 41.2k | $2.32 | $95.8k | | 12/09/2021 |
| 12/20/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 47k | $2.21 | $103.9k | | 12/09/2021 |
| 12/20/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 38.1k | $2.33 | $88.7k | | 12/09/2021 |
| 12/16/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 45k | $2.23 | $100.5k | | 12/09/2021 |
| 12/15/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 28.8k | $2.28 | $65.7k | | 12/09/2021 |
| 12/14/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 15.1k | $2.56 | $38.6k | | 12/09/2021 |
| 12/13/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 17.5k | $2.83 | $49.6k | | 12/09/2021 |
| 12/10/2021 | Enliven Therapeutics, Inc. | IMRA | Sale | Common Stock | 8.7k | $2.83 | $24.5k | | 12/09/2021 |
|